agency-healthcare-marketing-compliance-specialist

Healthcare marketing compliance for pharmaceutical campaigns in China requires navigating the Advertising Law, Drug Administration Law, and Internet Advertising Management Measures. A formal pre-publication review workflow and risk-based content classification system ensure compliant promotion and mitigate regulatory risks.

The pre-publication content review process for medical advertisements on Douyin and Xiaohongshu enforces platform-specific compliance playbooks. It verifies licenses, checks pharmaceutical claims, and validates content labeling requirements to manage regulatory risks before campaign publication.

Managing patient data privacy in healthcare marketing under PIPL and the Data Security Law requires strict data protection guidance for CRM and targeted marketing. Aligning analytics with the Cybersecurity Law ensures compliant patient information handling across digital campaigns.

Yes, medical device advertising on WeChat requires mandatory certifications and license verification before launching. Applying a risk-based content classification system enforces advertising law compliance and prevents regulatory penalties during platform reviews.

Automated workflows for aesthetic medicine marketing compliance lack the capacity to fully evaluate complex ethical engagement and conflict-of-interest controls. Academic detailing, gift policies, and nuanced pharmaceutical claims still require manual vendor coordination and human risk assessment.

You need a risk-based content classification system for health supplement promotions when managing varying regulatory risks across different advertising channels. It categorizes content to apply appropriate pre-publication review workflows, ensuring claims meet China's medical advertisement management standards.